State UT
Clinical Trials in Utah
Utah is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Utah and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 187 actively recruiting studies with Utah sites out of 187 registered in total. The busiest research areas in Utah are Multiple Myeloma, Heart Failure, Non-small Cell Lung Cancer. Leading sponsors running trials in the state include University of Utah, AstraZeneca, National Cancer Institute (NCI). By stage, Utah trials break down as Phase 1 (41), Phase 2 (58), Phase 3 (49), Phase 4 (2).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Utah
Frequently Asked Questions — Clinical Trials in Utah
How many clinical trials are currently recruiting in Utah?
ClinicalMetric currently tracks 187 actively recruiting clinical trials with at least one location in Utah. The total number of registered studies—including active but not currently enrolling trials—is 187. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Utah?
Utah hosts clinical trials across a broad range of medical conditions, including Multiple Myeloma, Heart Failure, Non-small Cell Lung Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Utah serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Utah?
To join a clinical trial in Utah, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Utah maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Utah
NCT06911632 N/A
Recruiting
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring ...
Condition
Pulmonary Hypertension
Enrollment
900 pts
Location
United States
Sponsor
Tempus AI
NCT07060716 N/A
Recruiting
Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monit...
Condition
Kidney Transplant Rejection
Enrollment
125 pts
Location
United States, Germany
Sponsor
Insight Molecular Diagnostics
NCT06585410 Phase 3
Recruiting
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous S...
Condition
Cutaneous Squamous Cell Carcinoma (CSCC)
Enrollment
369 pts
Location
United States, Australia
Sponsor
Regeneron Pharmaceuticals
NCT07361328 N/A
Recruiting
Personalized Ultrasonic Brain Stimulation for Fibromyalgia
Condition
Fibromyalgia (FM)
Enrollment
50 pts
Location
United States
Sponsor
University of Utah
NCT07589634 Phase 2
Recruiting
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Relea...
Condition
Multiple Myeloma
Enrollment
230 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT04763356 N/A
Recruiting
Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy
Condition
Chemotherapy-induced Peripheral Neuropathy
Enrollment
422 pts
Location
United States
Sponsor
University of Vermont
NCT07065760 N/A
Recruiting
University of Utah PS-IDE: Physician Modified Endovascular Grafts for the Treatm...
Condition
Juxtarenal Abdominal Aortic Aneurysm
Enrollment
15 pts
Location
United States
Sponsor
Cali Johnson
NCT06571162 N/A
Recruiting
A Pragmatic INitiative for LDL-C Management by a CLinical Pharmacist-Led Team Am...
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
400 pts
Location
United States
Sponsor
Intermountain Health Care, Inc
NCT06953960 Phase 1, Phase 2
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoc...
Condition
Multiple Myeloma
Enrollment
325 pts
Location
United States, Australia, Belgium
Sponsor
AbbVie
NCT07044583 N/A
Recruiting
SAVE Trial: SAfe Opioid Use Video Education
Condition
Breast Reconstruction
Enrollment
68 pts
Location
United States
Sponsor
University of Utah
NCT07110246 Phase 2
Recruiting
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
Condition
BRAF V600 Mutation
Enrollment
96 pts
Location
United States
Sponsor
University of California, San
NCT07611110 Phase 3
Recruiting
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-re...
Condition
Metastatic Castration-resistant Prostate Cancer
Enrollment
670 pts
Location
United States, Australia, Austria
Sponsor
AstraZeneca
NCT06678659 Phase 1, Phase 2
Recruiting
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Meta...
Condition
Unresectable
Enrollment
170 pts
Location
United States, Canada
Sponsor
Recursion Pharmaceuticals Inc.
NCT02998229 N/A
Recruiting
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bi...
Condition
Intracranial Aneurysm
Enrollment
300 pts
Location
United States
Sponsor
Medtronic Neurovascular Clinic
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT06419374 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With...
Condition
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Enrollment
1,800 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT07264959 N/A
Recruiting
An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)
Condition
Indolent Systemic Mastocytosis
Enrollment
150 pts
Location
United States
Sponsor
Blueprint Medicines Corporatio
NCT07093580 Phase 1
Recruiting
Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Condition
Healthy Participants
Enrollment
128 pts
Location
United States
Sponsor
Shionogi
NCT06710379 Phase 1
Recruiting
A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors
Condition
Solid Tumors
Enrollment
68 pts
Location
United States
Sponsor
Adcentrx Therapeutics
NCT07705373 N/A
Recruiting
A Novel Digital Music-based Autonomous Personalized Walking Intervention to Impr...
Condition
Parkinson's Disease (PD)
Enrollment
200 pts
Location
United States
Sponsor
Boston University Charles Rive
NCT05066217 Phase 3
Recruiting
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Sy...
Condition
Lennox Gastaut Syndrome
Enrollment
260 pts
Location
United States, China, Hungary
Sponsor
Epygenix
NCT07437950 Phase 2
Recruiting
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly ...
Condition
Acute Myeloid Leukemia
Enrollment
126 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT05413421 Phase 1
Recruiting
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Condition
Metastatic Prostate Cancer
Enrollment
275 pts
Location
United States, Australia, Spain
Sponsor
ORIC Pharmaceuticals
NCT02450006 N/A
Recruiting
Intermountain INSPIRE Registry
Condition
Condition
Enrollment
50,000 pts
Location
United States
Sponsor
Intermountain Health Care, Inc
NCT07511816 Phase 2
Recruiting
A Study of LY4515100 in Participants With Pain Following Third Molar Removal
Condition
Acute Pain
Enrollment
212 pts
Location
United States
Sponsor
Eli Lilly and Company
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology